Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
The Oncologist|April 6, 2017
Complete Metabolic Response on Interim 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Long-Term Survival in Patients with Breast Cancer Undergoing Neoadjuvant ChemotherapySuyun Chen, Nuhad K Ibrahim, Yuanqing Yan, et al.
Cancer Investigation|February 21, 2002
Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancerNuhad K Ibrahim, Zia Rahman, Vicente Valero, et al.
Cancer|August 8, 2015
Risk stratification in patients with advanced-stage breast cancer by pretreatment [(18) F]FDG PET/CTSuyun Chen, Nuhad K Ibrahim, Yuanqing Yan, et al.
European Journal of Radiology|June 8, 2007
Radiologic findings in taxane induced colitisHarmeet Kaur, Evelyne M Loyer, Cynthia L David, et al.
Oncology|June 27, 2009
Phase I study of prolonged-infusion gemcitabine combined with cyclophosphamide in patients with metastatic carcinoma of the breast: tolerability of an optimal dose scheduleFadi Estephan, Vicente Valero, Francisco J Esteva, et al.
Journal of Cancer|August 29, 2013
Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized TrialNuhad K Ibrahim, James L Murray, Dapeng Zhou, et al.
NPJ Breast Cancer|March 20, 2021
Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastasesOmar Alhalabi, Zaid Soomro, Ryan Sun, et al.
The Oncologist|March 25, 2015
Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysisQi Shen, Aysegul A Sahin, Kenneth R Hess, et al.
British Journal of Cancer|August 5, 2020
Central nervous system miliary metastasis in breast cancer: a case series analysis and proposed identification criteria of a rare metastasis subtypeSami I Bashour, Nuhad K Ibrahim, Donald F Schomer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2011
Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumorsDavid E Gerber, Alison T Stopeck, Lucas Wong, et al.
Pageof 7